{
  "documentMetadata": {
    "title": "Endocarditis, Candida",
    "lastUpdated": "2024-08-26",
    "sourceFile": "Endocarditis, Candida.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Signs and symptoms of endocarditis infection involving either native or prosthetic valve.",
        "Positive blood or valve cultures for Candida sp."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Candida albicans",
        "Other non-albicans Candida sp."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "regimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Caspofungin",
            "dose": "150 mg/day"
          },
          {
            "drug": "Micafungin",
            "dose": "150 mg/day",
            "connector": "or"
          },
          {
            "drug": "Anidulafungin",
            "dose": "200 mg/day",
            "connector": "or"
          }
        ]
      }
    },
    {
      "type": "regimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Lipid-based Amphotericin B",
            "dose": "3-5 mg/kg/day"
          },
          {
            "drug": "Flucytosine",
            "dose": "25 mg/kg",
            "frequency": "qid",
            "connector": "+"
          }
        ]
      }
    },
    {
      "type": "list",
      "items": [
        "Valve replacement strongly recommended whenever possible, particularly in those with prosthetic valve endocarditis."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "regimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Fluconazole",
            "dose": "400-800 mg",
            "route": "po"
          },
          {
            "drug": "(Lipid-based Amphotericin B",
            "dose": "3-5 mg/kg/day",
            "connector": "+"
          },
          {
            "drug": "an echinocandin)",
            "connector": "or"
          }
        ],
        "notes": "in stable patients with negative blood cultures and fluconazole susceptible organism"
      }
    },
    {
      "type": "list",
      "items": [
        "One of the above primary or alternative regimens followed by Fluconazole 400-800 mg/day for 6 months."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Duration of therapy:"
        },
        {
          "type": "list",
          "items": [
            "Treat for at least 6 weeks after valve replacement, longer in those with complications (e.g., perivalvular or myocardial abscess, extensive disease, delayed resolution of candidemia).",
            "Long-term, possibly life-long, suppression with Fluconazole 400-800 mg/day for prosthetic valve endocarditis if no valve replacement (Medicine 90:237, 2011)."
          ]
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Fluconazole monotherapy not recommended as primary treatment due to high failure rate; but may be used as a single agent following primary therapy for long-term suppression (Medicine 90:237, 2011). One observational study of prosthetic valve IE due to candida suggested that lipid-based Amphotericin B may be more effective than echinocandin therapy (Clin Infect Dis 66:825, 2018). However, mortality rate was high and surgery did not seem to be helpful.",
        "References: IDSA treatment guidelines: Clin Infect Dis 62:409, 2016 and Curr Opin Infect Dis 26:501, 2013."
      ]
    }
  ]
}
